Sale!
Ophthalmologic Drug Guide (Paperback) | Released: 01-Nov-06
By: Rhee,D.J., Colby,K.A. (Author) Publisher: Springer25.00% Off Original price was: 695.00$.521.00$Current price is: 521.00$.
You save 174.00$
Ophthalmology has long been considered a surgical area because so many disorders/diseases are treated surgically rather than medically. In the past ten years, however, there have been considerable therapeutic breakthroughs in non-surgical treatments. For instance, anti-glaucoma agents have becoming increasingly effective. This edition will include a new chapter for retinal... Read More
In stock
Ships within 1-2 Business Days
100% Orginal Books
Easy Replacement
Certified product
Secure Checkout
On time delivery
Author:
Rhee,D.J., Colby,K.A.
Publisher Name:
Springer
Language:
English
Binding:
(Paperback)
About The Book
Ophthalmology has long been considered a surgical area because so many disorders/diseases are treated surgically rather than medically. In the past ten years, however, there have been considerable therapeutic breakthroughs in non-surgical treatments. For instance, anti-glaucoma agents have becoming increasingly effective. This edition will include a new chapter for retinal disease. There are now several pharmaceutical agents being used to treat these diseases. Specifically, age-related macular degeneration has many new products a" macugen, lucentis, etc. a" and intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets have grown tremendously in the last 2-3 years (endura, restasis, xibrom, etc).This book contains all inclusive formulary for ocular prescription medications and includes new agents in retinal disease. Ophthalmology has long been considered a surgical area because so many disorders/diseases are treated surgically rather than medically. In the past ten years, however, there have been considerable therapeutic breakthroughs in non-surgical treatments. For instance, anti-glaucoma agents have become increasingly effective. This edition includes a new chapter for retinal disease. There are now several pharmaceutical agents being used to treat these diseases. Specifically, age-related macular degeneration has many new products.